The hypersecretion of GH/IGF-I in subjects with acromegaly is responsible for numerous adverse outcomes, with metabolic and cardiovascular complications being typically responsible for the increased mortality observed in these patients [2, 3]. Here, IGF1 is linked to acromegaly.